1 / 10

Inhalation Anesthesia Market Worth $1.42 Billion By 2025

Inhalation Anesthesia Market Size Share & Trends Analysis Report By Application (Induction, Maintenance), By Product (Sevoflurane, Isoflurane, Desflurane), By Region, And Segment Forecasts, 2019 - 2025

Marsh
Télécharger la présentation

Inhalation Anesthesia Market Worth $1.42 Billion By 2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Inhalation Anesthesia Market Analysis, Size, Growth, Share & Forecast to 2025 | Grand View Research Inc. “Inhalation Anesthesia Market Worth $1.42 Billion By 2025 | CAGR: 3.5%” The global Inhalation Anesthesia Market size is projected to reach USD 1.42 billion by 2025, at a lucrative CAGR of 3.5% over the forecast period, according to a new report by Grand View Research, Inc. Key factors contributing to its rapid growth include increasing prevalence of cancer, cardiovascular, respiratory, neurological, gastrointestinal, orthopedic, and spinal diseases and disorders. Furthermore, increasing number of emergency cases and demand for short stay ambulatory day care surgical procedure are amongst critical success factors attributed to the market growth. Access to universal health insurance coverage for a wider population base coupled with constant improvements in healthcare infrastructure in various developing countries are expected to positively impact the number of surgeries performed, thus increasing the usage of inhalation anesthetics. On the basis of product, the inhalation anesthesia market is classified into sevoflurane, isoflurane, and desflurane. These products are used for induction and maintenance of anesthesia for patients during surgical procedures. Sevoflurane led the product segment in 2018 and is anticipated to grow at a lucrative rate over the forecast period, attributed to its therapeutic advantages, low cost, and higher potency for the induction of anesthesia. On the other hand, isoflurane is expected to witness the fastest CAGR of 6.3% over the forecast period, due to its increasing use in maintenance of anesthesia for treatment of weak or geriatric patients owing to its sparing effect on cardiovascular function. On the basis of regions, the market is broadly classified into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa (MEA). North America held the leading market share of USD 456.0 million and is anticipated to witness lucrative CAGR over the forecast period. This is owing to increasing prevalence of chronic diseases coupled with the presence of advanced healthcare facilities. On the other hand, Asia Pacific Follow Us:

  2. was anticipated to witness the fastest CAGR of 4.0% due to increasing population and number of patients suffering from chronic population. Some of the key players operating in this market include Halocarbon Products Corporation; Baxter; Hikima Pharmaceuticals PLC; Lunan Pharmaceutical Group Co. Ltd.; Piramal Enterprises Limited; Jiangsu Hengrui Medicine Co. Ltd.; Fresenius Kabi AG, and AbbVie Inc. Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/inhalation- anesthesia-market Further key findings from the report suggest: Sevoflurane product segment led the market in terms of revenue, valued at USD 768.6 million, in 2018 • Isoflurane product segment is anticipated to expand at the fastest CAGR of 6.3% owing to its increasing use in the treatment of weak and geriatric patients owing to its low effect on cardiovascular function • North America led the market in 2018 with a revenue of USD 456.0 million owing to the presence of advanced healthcare facilities, strong reimbursement scenario, and prevalence of chronic diseases • Key players operating in the inhalation anesthesia market include Halocarbon Products Corporation; Baxter; Hikima Pharmaceuticals PLC; Lunan Pharmaceutical Group Co. Ltd.; Piramal Enterprises Limited; Jiangsu Hengrui Medicine Co. Ltd.; Fresenius Kabi AG, and AbbVie Inc. • Grand View Research has segmented the global inhalation anesthesia market on the basis of product and region: Inhalation Anesthesia Product Type Outlook (Revenue, USD Million, 2014 - 2025) Sevoflurane • Isoflurane • Desflurane • Inhalation Anesthesia Application Type Outlook (Revenue, USD Million, 2014 - 2025) Induction • Maintenance • Inhalation Anesthesia Regional Outlook (Revenue, USD Million, 2014 - 2025) NorthAmerica • oU.S. oCanada Follow Us:

  3. Europe • oGermany oU.K. oSpain oFrance oItaly oRussia AsiaPacific • oJapan oChina oIndia oSouth Korea oSingapore oAustralia Latin America • oBrazil oMexico oArgentina MEA • oSouth Africa oSaudi Arabia oUAE Table of Content Chapter 1 Methodology and Scope 1.1 Market Segmentation & Scope 1.2 Market Definition 1.3 Information Procurement Follow Us:

  4. 1.3.1 Purchased Database 1.3.2 GVR's Internal Database 1.3.3 Secondary Sources & Third Party perspectives 1.3.4 Primary Research 1.4 Information Analysis 1.4.1 Data Analysis Models 1.5 Market Formulation & Data Visualization 1.6 Data Validation & Publishing Chapter 2 Executive Summary 2.1 Inhalation anesthesia Market Outlook, By Revenue (USD Million) 2.2 Inhalation anesthesia Segment Outlook, By Revenue (USD Million) 2.3 Competititve Insights Chapter 3 Inhalation Anesthesia Market Variables, Trends and Scope 3.1 Market Lineage Outlook 3.1.1 Parent market outlook 3.1.2 Related/ancillary market outlook 3.2 Penetration & Growth Prospect Mapping 3.3 Product Pipeline Analysis, by Stage 3.4 Technology Overview 3.4.1 Technology timeline 3.5 Regulatory Framework 3.6 Market Dynamics 3.6.1 Market driver analysis 3.6.1.1 Higher patient outcome as compared to intravenous anesthesia 3.6.1.2 Increasing need to reduce hospital care cost 3.6.1.3 Rising number of surgical procedures 3.6.2 Market restraint analysis 3.6.2.1 Increasing concern about greenhouse gas emissions 3.6.3 Industry challenges 3.7 Inhalation anesthesia Market Analysis Tools 3.7.1 Industry analysis - Porter's 3.7.1.1 Supplier power 3.7.1.2 Buyer power 3.7.1.3 Substitution threat Follow Us:

  5. 3.7.1.4 New entrants threat 3.7.1.5 Competitive rivalry 3.7.2 PESTEL Analysis 3.7.2.1 Political landscape 3.7.2.2 Economic landscape 3.7.2.3 Social landscape 3.7.2.4 Technology landscape 3.7.3 Major deals and strategic alliances analysis 3.7.4 Market entry strategies Chapter 4 Inhalation Anesthesia Market - Competitive Analysis 4.1 Recent Developments & Impact Analysis, by Key Market Participants 4.2 Company/Competition Categorization 4.3 Public Companies 4.3.1 Company Market Position Analysis 4.3.2 Company Market Share/Ranking, by Region 4.4 Private Companies 4.4.1 List of Key Emerging Companies/Technology Disruptors/Innovators 4.4.2 Regional Network Map 4.4.3 Company Market Position Analysis Chapter 5 Inhalation Anesthesia Market: Product Type Estimates & Trend Analysis 5.1 Definitions & Scope 5.2 Inhalation anesthesia Market Share by Product Type, 2018 & 2025 5.3 Segment Dashboard 5.4 Sevoflurane 5.4.1 Sevoflurane market estimates and forecasts, 2014 - 2025 (USD Million) 5.4.2 Sevoflurane market estimates and forecasts, by application, 2014 - 2025 (USD Million) 5.5 Desflurane 5.5.1 Desflurane market estimates and forecasts, 2014 - 2025 (USD Million) 5.5.2 Desflurane market estimates and forecasts, by application, 2014 - 2025 (USD Million) 5.6 Isoflurane 5.6.1 Isoflurane market estimates and forecasts, 2014 - 2025 (USD Million) 5.6.2 Isoflurane market estimates and forecasts, 2014 - 2025 by application (USD Million) Chapter 6 Inhalation anesthesia Market: Application Type Estimates & Trend Analysis 6.1 Definitions & Scope Follow Us:

  6. 6.2 Inhalation anesthesia Market Share by Application Type, 2018 & 2025 6.3 Segment Dashboard 6.4 Induction 6.4.1 Induction market estimates and forecasts, 2014 - 2025 (USD Million) 6.5 Maintenance 6.5.1 Maintenance market estimates and forecasts, 2014 - 2025 (USD Million) Chapter 7 Inhalation anesthesia Market: Regional Estimates & Trend Analysis, by Product 7.1 Regional Market Snapshot 7.2 Regional Market Share and Leading Players, 2018 7.2.1 North America 7.2.2 Europe 7.2.3 Asia Pacific 7.2.4 Latin America 7.2.5 Middle East & Africa 7.3 SWOT Analysis, by Factor (Political & Legal, Economic and Technological) 7.3.1 North America 7.3.2 Europe 7.3.3 Asia Pacifc 7.3.4 Latin America 7.3.5 Middle East & Africa 7.4 Market Size, & Forecasts, and Trend Analysis, 2018 to 2025: 7.4.1 North America 7.4.1.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 7.4.1.2 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 7.4.1.3 U.S. 7.4.1.3.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 7.4.1.3.2 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 7.4.1.4 Canada 7.4.1.4.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 7.4.1.4.2 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 7.4.2 Europe 7.4.2.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 7.4.2.2 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 7.4.2.3 U.K. Follow Us:

  7. 7.4.2.3.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 7.4.2.3.2 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 7.4.2.4 Germany 7.4.2.4.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 7.4.2.4.2 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 7.4.2.5 Spain 7.4.2.5.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 7.4.2.5.2 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 7.4.2.6 France 7.4.2.6.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 7.4.2.6.2 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 7.4.2.7 Italy 7.4.2.7.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 7.4.2.7.2 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 7.4.2.8 Russia 7.4.2.8.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 7.4.2.8.2 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 7.4.3 Asia Pacific 7.4.3.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 7.4.3.2 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 7.4.3.3 China 7.4.3.3.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 7.4.3.3.2 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 7.4.3.4 Japan 7.4.3.4.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 7.4.3.4.2 Market estimates and forecasts, by applciation 2014 - 2025 (USD Million) 7.4.3.5 India 7.4.3.5.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 7.4.3.5.2 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 7.4.3.6 South Korea 7.4.3.6.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 7.4.3.6.2 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 7.4.3.7 Singapore 7.4.3.7.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) Follow Us:

  8. 7.4.3.7.2 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 7.4.3.8 Australia 7.4.3.8.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 7.4.3.8.2 Market estimates and forecasts, by applciation 2014 - 2025 (USD Million) 7.4.4 Latin America 7.4.4.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 7.4.4.2 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 7.4.4.3 Brazil 7.4.4.3.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 7.4.4.3.2 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 7.4.4.4 Mexico 7.4.4.4.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 7.4.4.4.2 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 7.4.4.5 Argentina 7.4.4.5.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 7.4.4.5.2 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 7.4.5 Middle East & Africa (MEA) 7.4.5.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 7.4.5.2 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 7.4.5.3 South Africa 7.4.5.3.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 7.4.5.3.2 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 7.4.5.4 Saudi Arabia 7.4.5.4.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 7.4.5.4.2 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 7.4.5.5 UAE 7.4.5.5.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 7.4.5.5.2 Market estimates and forecasts, by application 2014 - 2025 (USD Million) Chapter 8 Competitive Landscape 8.1 Company Profiles 8.1.1 Halocarbon Products Corporation 8.1.1.1 Company Overview 8.1.1.2 Financial Performance 8.1.1.3 Product Benchmarking Follow Us:

  9. 8.1.1.4 Strategic Initiatives 8.1.2 Baxter 8.1.2.1 Company Overview 8.1.2.2 Financial Performance 8.1.2.3 Product Benchmarking 8.1.2.4 Strategic Initiatives 8.1.3 Hikima Pharmaceuticals plc. 8.1.3.1 Company Overview 8.1.3.2 Financial Performance 8.1.3.3 Product Benchmarking 8.1.3.3 Strategic Initiatives 8.1.4 Luman Pharmaceutical Group Co., Ltd 8.1.4.1 Company Overview 8.1.4.2 Financial Performance 8.1.4.3 Product Benchmarking 8.1.4.4 Strategic Initiatives 8.1.5 Piramal Enterprises Limited 8.1.5.1 Company Overview 8.1.5.2 Financial Performance 8.1.5.3 Product Benchmarking 8.1.5.4 Strategic Initiatives 8.1.6 Jiangsu Hengrui Medicine Co. Ltd. 8.1.6.1 Company Overview 8.1.6.2 Financial Performance 8.1.6.3 Product Benchmarking 8.1.6.4 Strategic Initiatives 8.1.7 Fresenius Kabi AG 8.1.7.1 Company Overview 8.1.7.2 Financial Performance 8.1.7.3 Product Benchmarking 8.1.7.4 Strategic Initiatives 8.1.8 AbbVie Inc. 8.1.8.1 Company Overview 8.1.8.2 Financial Performance Follow Us:

  10. 8.1.8.3 Product Benchmarking 8.1.8.4 Strategic Initiatives 8.2 List of Other Manufacturers About Grand View Research, Inc.: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email:sales@grandviewresearch.com For More Information:https://www.grandviewresearch.com Follow Us:

More Related